[
    {
        "id": "Case503",
        "patient_info": "A 2-year-old child is being evaluated for a history of a high-risk brief resolved unexplained event and recurrent witnessed seizure-like episodes; a prior chromosomal microarray was non-diagnostic, and whole exome sequencing has been ordered by the nurse practitioner, with pre-test genetic counseling completed and post-test counseling planned; the family history is notable for parental consanguinity (the parents are first cousins), and the child is insured through Blue Cross Blue Shield Federal Employee Program (FEP)."
    },
    {
        "id": "Case811",
        "patient_info": "At 7 weeks of age, the infant was evaluated by a general pediatrician for early-onset movement disorder with abnormal neurologic findings, and after a nondiagnostic chromosomal microarray, clinical whole exome sequencing (WES) was ordered; the family history is notable for an older sibling with multiple congenital anomalies, the patient is insured through the Blue Cross Blue Shield Federal Employee Program (BCBS FEP), and the family met with a genetic counselor prior to testing with plans for post-test counseling once results are available."
    },
    {
        "id": "Case17",
        "patient_info": "A 4-year-old child with early-onset epileptic encephalopathy beginning before age three is being evaluated by a pediatric neurologist; no prior epilepsy multigene panel has been performed, and a chromosomal microarray completed previously was non-diagnostic. Family history is notable for an older brother with unexplained developmental regression unrelated to autism or epilepsy. Whole exome sequencing is being ordered to investigate an underlying genetic etiology, and the case has been discussed with a genetics specialist for pre-test counseling, with follow-up counseling planned after results. Insurance coverage is through Cigna."
    },
    {
        "id": "Case884",
        "patient_info": "At 32 weeks\u2019 gestation, a fetus is being evaluated for concern of a neurologic abnormality. A Developmental Pediatrician has ordered prenatal whole exome sequencing after prior karyotype testing was non-diagnostic; the family reports an older sibling with multiple congenital anomalies, they have UHC insurance, and the parents declined genetic counseling."
    },
    {
        "id": "Case647",
        "patient_info": "NO\nA prenatal fetus cannot manifest or be assessed for developmental regression, making this neurodevelopmental indication unrealistic."
    },
    {
        "id": "Case710",
        "patient_info": "A 73-year-old patient is being evaluated by a medical geneticist for a history of intrauterine fetal demise (stillbirth); whole exome sequencing has been ordered to assess for potential genetic contributors after prior fluorescence in situ hybridization (FISH) testing was non-diagnostic, there is a family history of a sibling with dysmorphic features, no genetic counseling was conducted before testing, and insurance coverage is through the Blue Cross Blue Shield Federal Employee Program (FEP)."
    },
    {
        "id": "Case373",
        "patient_info": "At 25 weeks\u2019 gestation, a fetus was noted on prenatal imaging to have multiple structural anomalies without a unifying syndromic diagnosis; prior FISH testing was non-diagnostic, and the obstetrician is now pursuing prenatal whole-exome sequencing to investigate an underlying genetic cause, with coverage requested through UHC; family history is notable for breast cancer in the father."
    },
    {
        "id": "Case120",
        "patient_info": "NO\nA 15-year-old being managed by a neonatologist is unrealistic due to the age\u2013provider mismatch."
    },
    {
        "id": "Case661",
        "patient_info": "NO\nA 2-week-old infant cannot have multiple primary breast cancers, an adult-onset condition, so the indication is impossible for this age."
    },
    {
        "id": "Case13",
        "patient_info": "At 0 weeks of age, a neonate with multiple congenital anomalies without a recognizable syndrome pattern is being evaluated; a prior karyotype was non-diagnostic, and the general pediatrician has ordered whole exome sequencing (WES) to aid in diagnosis, with the family reporting an older sibling who experienced unexplained developmental regression not attributable to autism or epilepsy; the infant is covered by BCBS FEP, and the family met with a genetic counselor before testing with follow-up counseling planned after results are available."
    },
    {
        "id": "Case955",
        "patient_info": "NO\nA 60-year-old adult being managed by a pediatric neurologist is unrealistic, as pediatric subspecialists care for children rather than adults."
    },
    {
        "id": "Case452",
        "patient_info": "A 3-week-old infant with an ocular coloboma is being evaluated, and a nurse practitioner has ordered whole exome sequencing after prior karyotype testing was non-diagnostic; there is a family history of dysmorphic features in the mother, the case was discussed with a genetic specialist for pre-test counseling with plans for post-test counseling after results, and the testing will be billed to Cigna."
    },
    {
        "id": "Case333",
        "patient_info": "NO\nGlobal developmental delay is a pediatric-only diagnosis and is not a realistic indication for a 59-year-old adult."
    },
    {
        "id": "Case457",
        "patient_info": "NO\nA 70-year-old evaluated for multiple congenital anomalies is unrealistic here because congenital-anomaly indications are pediatric-only."
    },
    {
        "id": "Case794",
        "patient_info": "NO\nAssigning a neurodevelopmental presentation (hypotonia/hypertonia in infancy) to a 21-week fetus is incompatible with a prenatal case."
    },
    {
        "id": "Case3",
        "patient_info": "At 17 years of age, the patient carries a recent diagnosis of epithelial ovarian cancer and is being evaluated for hereditary risk; a cardiologist ordered whole exome sequencing, and prior FISH testing was non-diagnostic. Family history is notable for a mother who developed breast cancer at age 45. The patient has met with a genetic counselor multiple times for pre-test counseling, with additional follow-up planned to review results and implications. Testing will be processed under Cigna insurance."
    },
    {
        "id": "Case160",
        "patient_info": "At 9 years of age, the child with a history of multiple congenital anomalies is undergoing whole exome sequencing (WES) ordered by the family medicine physician, after prior FISH testing was non-diagnostic; the family history is notable for an older brother with short stature, and the patient met with a genetic counselor before testing and will follow up after results are available, with insurance coverage through the Blue Cross Blue Shield Federal Employee Program (FEP)."
    },
    {
        "id": "Case556",
        "patient_info": "A 14-year-old with a history of multiple congenital anomalies is being evaluated by a neurologist, with no prior genetic testing to date; family history is notable for a maternal aunt who carries a known pathogenic BRCA2 variant, and whole exome sequencing is being pursued to investigate an underlying genetic etiology. The case was discussed pre-test with a genetic specialist, and post-test counseling is planned. The patient is insured through UHC."
    },
    {
        "id": "Case542",
        "patient_info": "At 38 weeks\u2019 gestation, a fetus with multiple congenital anomalies affecting different organ systems identified on prenatal imaging is being evaluated for an underlying genetic etiology; whole-exome sequencing has been ordered by the mother\u2019s oncologist after prior prenatal FISH testing was non-diagnostic, the family history is notable for pancreatic cancer in the mother, and testing will be billed to UHC insurance."
    },
    {
        "id": "Case805",
        "patient_info": "NO\nEvaluating a 27-year-old for multiple congenital anomalies is a pediatric-only indication and therefore inconsistent with an adult patient."
    },
    {
        "id": "Case499",
        "patient_info": "NO\nA 1-year-old child being managed by a neonatologist is unrealistic, as neonatologists care for neonates rather than children."
    },
    {
        "id": "Case881",
        "patient_info": "At 2 weeks of age, the patient is undergoing evaluation for possible intellectual disability, with whole-genome sequencing ordered by the cardiologist; prior FISH testing was non-diagnostic, and the family history is notable for an older brother with unexplained developmental regression not attributable to autism or epilepsy. The patient was seen by a genetic counselor before testing and has planned post-test follow-up. Insurance coverage is through the Blue Cross Blue Shield Federal Employee Program (FEP)."
    },
    {
        "id": "Case583",
        "patient_info": "A 7-week-old infant was evaluated by a developmental pediatrician for global developmental delay, with concerns noted since birth; prior FISH testing was non-diagnostic. The family history is notable for an older brother with global developmental delay. Whole-genome sequencing is being ordered to investigate an underlying genetic cause, coordinated by the developmental pediatrician, and the patient is insured by UHC."
    },
    {
        "id": "Case129",
        "patient_info": "The patient is a 12-year-old with a complex neurodevelopmental disorder including autism, managed by a neurologist; prior chromosomal microarray testing was non-diagnostic, and there is a family history of long QT syndrome in the patient\u2019s father. Whole-genome sequencing is being ordered to investigate a genetic cause, with insurance through UHC."
    },
    {
        "id": "Case681",
        "patient_info": "At 1 year of age, the child is being evaluated for a history of meconium ileus; an oncologist is ordering whole-genome sequencing to assess for a genetic etiology after a prior chromosomal microarray was non-diagnostic, the family history is notable for a maternal uncle with dystonia, and insurance is through UHC."
    },
    {
        "id": "Case609",
        "patient_info": "NO\nA 15-year-old being managed by a neonatologist is unrealistic, as neonatologists care for newborns rather than adolescents."
    },
    {
        "id": "Case732",
        "patient_info": "At 19 years of age, the patient presents for genetic evaluation of a personal history of breast cancer at a young age, with testing ordered by a pediatric neurologist and insurance through the Blue Cross Blue Shield Federal Employee Program (FEP); prior karyotype testing was non-diagnostic, and whole\u2011genome sequencing is being pursued, with family history additionally notable for a maternal uncle who reportedly had laboratory abnormalities suggestive of an inborn error of metabolism."
    },
    {
        "id": "Case135",
        "patient_info": "NO\nA 1-year-old child being managed by a neonatologist is not allowed by the age\u2013provider rules."
    },
    {
        "id": "Case837",
        "patient_info": "A 5-year-old child with a history of choanal atresia is being evaluated by an oncologist, who is ordering whole-genome sequencing to assess for an underlying genetic etiology; prior Fragile X testing was non-diagnostic, and the family history is notable for the mother having an arrhythmia; testing will be billed to UHC."
    },
    {
        "id": "Case132",
        "patient_info": "At 7 weeks of age, an infant is being evaluated by a general pediatrician for early developmental concerns raising suspicion for intellectual disability; a prior chromosomal microarray was nondiagnostic, and there is a family history of ovarian carcinoma in the maternal grandmother. Whole-genome sequencing has been ordered following pre-test genetic counseling, with plans for post-test counseling once results are available, and testing will be billed to UHC."
    },
    {
        "id": "Case887",
        "patient_info": "NO\nBRUE (brief resolved unexplained event) is defined only for infants under 1 year, so applying \u201chigh-risk BRUE\u201d to a 47-year-old is an age\u2013indication impossibility."
    },
    {
        "id": "Case426",
        "patient_info": "A 15-year-old is being seen by a gynecologist for lobular breast cancer, with a family history of diffuse gastric cancer in a maternal aunt; there has been no prior genetic testing. The gynecologist is ordering germline BRCA1/2 testing, the family history also includes a brother with autism spectrum disorder, and insurance is Cigna."
    },
    {
        "id": "Case131",
        "patient_info": "A 3-week-old infant with persistent generalized hypotonia is being evaluated by the primary care physician, who has ordered BRCA1/2 testing; prior FISH testing was non-diagnostic. The family reports an older brother with severe intellectual disability diagnosed in childhood, and they have met with a genetic counselor multiple times with plans for post-test counseling after results return. Coverage is through Cigna."
    },
    {
        "id": "Case251",
        "patient_info": "At 27 years of age, the patient has a history of congenital choanal atresia and no prior genetic testing, and is being evaluated given a family history notable for a father with metastatic prostate cancer; a Family Medicine Physician is ordering BRCA1/2 testing to clarify inherited cancer risk, with coverage through UHC."
    },
    {
        "id": "Case157",
        "patient_info": "A 1-year-old child is being seen by a developmental pediatrician for significant developmental delay concerning for severe intellectual disability; prior karyotype testing was non-diagnostic. There is a family history of an older sibling with laboratory abnormalities suggestive of an inborn error of metabolism. The provider is ordering BRCA1/2 testing, and the patient is insured through UHC."
    },
    {
        "id": "Case836",
        "patient_info": "A 4-week-old infant with clinical features concerning for Hirschsprung disease was evaluated by a Family Medicine Physician; prior chromosomal microarray testing was non-diagnostic, and the family reports an older brother with severe intellectual disability diagnosed in early childhood; the parents have met with a genetic counselor multiple times for pre-test counseling with post-test follow-up planned, and BRCA1/2 germline testing has been ordered; insurance is UHC."
    },
    {
        "id": "Case762",
        "patient_info": "NO\nPrenatal BRCA1/2 testing on a 20-week fetus is unrealistic because adult-onset cancer susceptibility single-gene testing is not performed prenatally."
    },
    {
        "id": "Case979",
        "patient_info": "A 30-year-old man with a recent diagnosis of breast cancer is having germline BRCA1/2 testing ordered by his cardiologist; prior FISH testing was non-diagnostic. He reports a brother with an inborn error of metabolism but no known family history of breast or ovarian cancer. He has met with a genetic counselor multiple times for pre-test counseling and will follow up after results are available. Testing will be billed to UHC."
    },
    {
        "id": "Case22",
        "patient_info": "An 18-year-old with high-risk prostate cancer exhibiting intraductal/cribriform features was referred by a neurologist for germline risk assessment, with BRCA1/2 testing ordered given a family history of a father with metastatic prostate cancer; prior chromosomal microarray testing was non-diagnostic, coverage is through BCBS_FEP, and the patient met with a genetic counselor before testing with follow-up counseling planned after results are available."
    },
    {
        "id": "Case722",
        "patient_info": "NO\nUnrealistic because it lists a pediatric-only indication (hypotonia or hypertonia in infancy) for a 35-year-old adult."
    },
    {
        "id": "Case943",
        "patient_info": "A 5-year-old child with autism spectrum disorder and a congenital anomaly confined to a single organ system is being evaluated; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic. A Family Medicine Physician has ordered BRCA1/2 testing, and the patient saw a genetic counselor before testing with plans for follow-up after results. Family history is notable for a maternal cousin with an inborn error of metabolism. Coverage is through UHC."
    },
    {
        "id": "Case908",
        "patient_info": "At 14 years of age, the patient was recently diagnosed with triple-negative breast cancer and is being evaluated for hereditary risk with BRCA1/2 testing; the test was ordered by the cardiologist, prior karyotype testing was non-diagnostic, and the family history is notable for a brother with lifelong short stature; genetic counseling was offered but declined, and coverage is through Cigna."
    },
    {
        "id": "Case259",
        "patient_info": "A 1-year-old child with congenital ocular coloboma is being evaluated, and due to a family history of a known BRCA2 pathogenic variant in the mother, a cardiologist has ordered BRCA1/2 testing; prior Fragile X testing was non-diagnostic, the family declined genetic counseling at this time, and coverage is through UHC."
    },
    {
        "id": "Case392",
        "patient_info": "A 4-week-old infant with a significant congenital heart defect is being evaluated; prior karyotype testing was nondiagnostic. A neurologist ordered germline BRCA1/2 testing in the context of a family history notable for a maternal aunt diagnosed with a Lynch syndrome\u2013associated cancer before age 50. The patient is insured through BCBS_FEP. The family met with a genetic counselor before testing and will return for post-test counseling once results are available."
    },
    {
        "id": "Case99",
        "patient_info": "NO\nCongenital anomalies as the clinical indication is pediatric-only and therefore inconsistent for a 37-year-old adult."
    },
    {
        "id": "Case628",
        "patient_info": "A 62-year-old patient with epileptic encephalopathy that began before age 3 is being evaluated by a medical geneticist; there has been no prior epilepsy multigene panel or other genetic testing, and the family history is notable for a brother with an inborn error of metabolism; a tumor-type chromosomal microarray has been ordered, pre-test counseling was discussed with a genetics specialist with plans for follow-up, and testing will be billed to Cigna."
    },
    {
        "id": "Case31",
        "patient_info": "At 19 years of age, the patient is being evaluated for significant generalized hypotonia with no prior genetic testing; the cardiologist is ordering a chromosomal microarray to assess for copy number variants that could explain the presentation, the patient has BCBS FEP coverage, and the family history is notable for a maternal aunt with epithelial ovarian cancer; the patient met with a genetic counselor before testing and will return for post-test counseling once results are available."
    },
    {
        "id": "Case418",
        "patient_info": "A 24-year-old patient with a history of epileptic encephalopathy, with seizures beginning before age three, is being evaluated for a genetic etiology; there has been no prior genetic testing. A chromosomal microarray is being ordered by a nurse practitioner, and genetic counseling was offered but declined. Family history is notable for a mother with long QT syndrome. Insurance coverage is through the Blue Cross Blue Shield Federal Employee Program (FEP)."
    },
    {
        "id": "Case27",
        "patient_info": "A 69-year-old patient is being evaluated for progressive movement disorder symptoms characterized by dystonia and gait ataxia. A Family Medicine Physician has ordered chromosomal microarray (CMA) for further evaluation after a prior chromosomal microarray was nondiagnostic; the family history is notable for a sister with triple-negative breast cancer, the patient is insured through the Blue Cross Blue Shield Federal Employee Program, and they have declined genetic counseling at this time."
    },
    {
        "id": "Case792",
        "patient_info": "At 19 years of age, the patient is being evaluated for lifelong multiple congenital anomalies, with family history notable for a brother with global developmental delay; a prior chromosomal microarray was non-diagnostic, and the family medicine physician is ordering chromosomal microarray analysis for developmental disorders with pre-test counseling completed by a genetics specialist and plans for post-test follow-up, and coverage through UHC."
    }
]